StockData
Centene Corp logo

Centene Corp (CNC) stock

CNCNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 7/302% above fair value
$67.45−5.10 (-7.03%)

Close on Nov 18, 2026Market cap $33.39BP/E 23.1Yield –

Centene free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Centene's free cash flow for the twelve months ending Sep 30, 2026 was $3.94B, up 17.5% year over year. For fiscal 2025 it was $4.32B. Over ten years it grew 23.9% a year on average. The highest annual figure on record is $7.25B in fiscal 2023.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.32B–
FY2024Dec 31, 2024-$490.00M-106.8%
FY2023Dec 31, 2023$7.25B+38.0%
FY2022Dec 31, 2022$5.26B+59.5%
FY2021Dec 31, 2021$3.30B-28.9%
FY2020Dec 31, 2020$4.63B+515.4%
FY2019Dec 31, 2019$753.00M+34.7%
FY2018Dec 31, 2018$559.00M-47.6%
FY2017Dec 31, 2017$1.07B-30.9%
FY2016Dec 31, 2016$1.55B+204.1%
FY2015Dec 31, 2015$508.00M-54.6%
FY2014Dec 31, 2014$1.12B+256.7%
FY2013Dec 31, 2013$314.00M+59.4%
FY2012Dec 31, 2012$197.00M+4.8%
FY2011Dec 31, 2011$187.99M+273.2%
FY2010Dec 31, 2010$50.38M-77.6%
FY2009Dec 31, 2009$224.47M+43.1%
FY2008Dec 31, 2008$156.82M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$3.86B-437.4%
Q2 FY2026Jun 30, 2026$3.42B+116.6%
Q1 FY2026Mar 31, 2026$4.17B+203.0%
Q4 FY2025Dec 31, 2025$224.00M–
Q3 FY2025Sep 30, 2025$1.15B–
Q2 FY2025Jun 30, 2025$1.58B-20.7%
Q1 FY2025Mar 31, 2025$1.38B–
Q4 FY2024Dec 31, 2024-$741.00M–
Q3 FY2024Sep 30, 2024-$1.13B-227.8%
Q2 FY2024Jun 30, 2024$1.99B-14.7%
Q1 FY2024Mar 31, 2024-$607.00M-115.0%
Q4 FY2023Dec 31, 2023-$6.00M–
Q3 FY2023Sep 30, 2023$885.00M-71.3%
Q2 FY2023Jun 30, 2023$2.33B-24.1%
Q1 FY2023Mar 31, 2023$4.04B+344.9%
Q4 FY2022Dec 31, 2022-$1.81B-523.7%
Q3 FY2022Sep 30, 2022$3.09B+95.6%
Q2 FY2022Jun 30, 2022$3.07B+114.1%
Q1 FY2022Mar 31, 2022$909.00M–
Q4 FY2021Dec 31, 2021$427.00M-84.6%
Q3 FY2021Sep 30, 2021$1.58B–
Q2 FY2021Jun 30, 2021$1.44B-58.8%
Q1 FY2021Mar 31, 2021-$144.00M–
Q4 FY2020Dec 31, 2020$2.78B–
Q3 FY2020Sep 30, 2020-$1.20B–
Q2 FY2020Jun 30, 2020$3.48B+359.6%
Q1 FY2020Mar 31, 2020-$417.00M-136.6%
Q4 FY2019Dec 31, 2019-$851.00M–
Q3 FY2019Sep 30, 2019-$293.00M-169.6%
Q2 FY2019Jun 30, 2019$757.00M–
Q1 FY2019Mar 31, 2019$1.14B-30.0%
Q4 FY2018Dec 31, 2018-$820.00M-349.2%
Q3 FY2018Sep 30, 2018$421.00M–
Q2 FY2018Jun 30, 2018-$670.00M–
Q1 FY2018Mar 31, 2018$1.63B+39.7%
Q4 FY2017Dec 31, 2017$329.00M-78.0%
Q3 FY2017Sep 30, 2017-$23.00M–
Q2 FY2017Jun 30, 2017-$404.00M–
Q1 FY2017Mar 31, 2017$1.17B–
Q4 FY2016Dec 31, 2016$1.50B–

More Centene figures

See a number that looks wrong?